Physician profile
Lew C Schon
NPI 1740224930
$752,193.20
in general payments reported to CMS, 2019-2025
27 companies · $111K in 2025
The $111K reported for 2025 was more than what 95% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124K · 2020: $56K · 2021: $74K · 2022: $100K · 2023: $173K · 2024: $114K · 2025: $111K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $242K · Consulting Fee: $94K · Education: $53K · Travel and Lodging: $6,479 · Food and Beverage: $2,163 · Entertainment: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $242,472.39 |
| Consulting Fee | $93,993.75 |
| Education | $53,014.51 |
| Travel and Lodging | $6,478.62 |
| Food and Beverage | $2,162.88 |
| Entertainment | $238.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $392,312.83 | 2019-2025 | Trabecular Metal, Accufill, Persona |
| Arthrex, INC. | $212,541.62 | 2019-2025 | Arthrex |
| Paragon 28, INC. | $71,135.86 | 2019-2025 | Portfolio |
| Djo, LLC | $53,707.83 | 2019-2025 | Aircast, Procare |
| Carestream Health, INC. | $7,316.48 | 2019-2020 | |
| Wright Medical Technology, INC. | $6,155.19 | 2019-2020 | |
| Avitus Orthopaedics, INC. | $2,000.00 | 2021-2022 | |
| Mirus, LLC | $1,500.00 | 2019-2020 | |
| Stryker Corporation | $1,305.81 | 2019-2025 | Inbone, Augment Injectable, Prostep Mica |
| Supreme Orthopedic Systems, LLC | $1,211.19 | 2022 | |
| Southtech Orthopedics | $1,200.00 | 2022 | |
| Arteriocyte Medical Systems, INC. | $279.26 | 2019-2021 | |
| Ossio INC | $250.46 | 2022-2023 | |
| Curvebeam LLC | $238.21 | 2023 | |
| Acuitive Technologies, INC | $154.03 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $146.43 | 2021 | |
| Medical Device Business Services, INC. | $137.01 | 2024 | Stratafix |
| Davol INC. | $132.67 | 2022 | |
| Ethicon US, LLC | $120.61 | 2024-2025 | Stratafix, Dermabond Prineo |
| Biocomposites INC | $118.92 | 2020-2025 | Stimulan |
| Grt US Holding, INC. | $105.50 | 2022 | |
| Baxter Healthcare | $39.80 | 2022 | |
| Linvatec Corporation | $33.95 | 2024-2025 | Biobrace 23mm, Hercules Suture Anchor System, Allograft Tissue |
| Averitas Pharma INC. | $17.71 | 2024 | Qutenza |
| Smith+Nephew, INC. | $16.65 | 2019 | |
| Solventum Corporation | $15.18 | 2025 | Prevena |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$196,985.09 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lew Schon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.